MF
AVNS

Magnetar Financial’s Avanos Medical AVNS Stock Holding History

Magnetar Financial’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-43,687
Closed -$491K – 1153
2025
Q4 		$491K Buy
43,687
+9,604
+28% +$110K ﹤0.01% 563
2025
Q3 		$394K Sell
34,083
-34,838
-51% -$408K ﹤0.01% 642
2025
Q2 		$844K Buy
+68,921
New +$867K ﹤0.01% 465
2024
Q3 		– Sell
-12,437
Closed -$248K – 531
2024
Q2 		$248K Buy
+12,437
New +$242K 0.01% 423
2019
Q4 		– Sell
-13,633
Closed -$511K – 532
2019
Q3 		$511K Buy
13,633
+432
+3% +$16.5K 0.01% 338
2019
Q2 		$576K Buy
+13,201
New +$565K 0.01% 278
2018
Q3 		– Sell
-6,021
Closed -$345K – 518
2018
Q2 		$345K Buy
+6,021
New +$318K 0.01% 347

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Magnetar Financial's AVNS Position: Q1 2026 in Review

Magnetar Financial sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 43,687 shares — an estimated $491K sold.

Magnetar Financial first reported a position in AVNS in Q2 2018 and held it in 7 quarters. The position peaked at $844K in Q2 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Magnetar Financial reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Magnetar Financial sold 43,687 Avanos Medical shares in Q1 2026, an estimated $491K.
  • Magnetar Financial first reported a position in Avanos Medical in Q2 2018 and held it in 7 quarters.
  • Magnetar Financial's Avanos Medical position peaked at $844K in Q2 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.